Functional Bowel Disorders, Psychosocial Correlates and Health-related Quality of Life in a Nigerian Community: Ilisan-Remo Functional Bowel Disorders Project Protocol

Main Article Content

Abiodun Christopher Jemilohun
Kolowole Oluseyi Akande
Olufunke Oluwatosin Adeleye
Charles John Elikwu
Oluwatoyin Adetutu Fasesan
Theophilus Oludare Ajiro


Introduction: Functional bowel disorders are functional gastrointestinal disorders affecting the middle or lower gastrointestinal tract. They occur worldwide and manifest with features of abdominal pain, bloating, distention, and/or bowel habit abnormalities such as diarrhea, constipation, or mixed diarrhea and constipation. Though benign, their interference with the patient’s daily activities constitutes a substantial socioeconomic burden. There is paucity of data concerning the functional bowel disorders and their psychosocial correlates, apart from irritable bowel syndrome, in Nigeria. More especially, these disorders have not been studied with the Rome IV iteration in the country. This study aims at bridging the observed gaps. 

Materials and Methods: The study shall be a descriptive cross-sectional community-based study. The study population shall consist of a cohort of 500 consenting adults aged 18 to 70 years who are residents of Ilisan-Remo, Ogun State, Nigeria. A composite questionnaire consisting of demographic data, medication history, the Rome IV Functional Bowel Disorder questionnaire, the Becks Anxiety, and Depression Inventories, the Pittsburgh Sleep Quality Index, the Early Trauma Inventory-Self Report, Short Form 12, version 2 Health Survey (SF-12v2) questionnaire and other relevant questions shall be used to obtain data from the participants. We shall analyze the data obtained with the IBM- Statistical Package for Social Sciences (SPSS), version 22.

Discussion: The present study would be the first study to investigate a group of FBDs in Nigerian community using the Rome IV criteria. The study would investigate the association between the FBDs and a comprehensive list of prospective risk factors which include anxiety, depression, early trauma exposure, sleep quality, abdominal obesity, cigarette smoking, alcohol consumption, coffee intake, and physical exercise in a Nigerian population. It would also evaluate the health-related quality of life in persons who suffer from the FBDs and help to create awareness of the diseases.

Conclusion: When completed, this study would provide vital information concerning the prevalence, risk factors and health-related quality of life of functional bowel disorders in a black African population.

Functional bowel disorders, irritable bowel syndrome, functional constipation, functional diarrhea, risk factors, health-related quality of life.

Article Details

How to Cite
Jemilohun, A. C., Akande, K. O., Adeleye, O. O., Elikwu, C. J., Fasesan, O. A., & Ajiro, T. O. (2020). Functional Bowel Disorders, Psychosocial Correlates and Health-related Quality of Life in a Nigerian Community: Ilisan-Remo Functional Bowel Disorders Project Protocol. International Research Journal of Gastroenterology and Hepatology, 3(1), 1-9. Retrieved from
Study Protocol


Drossman DA. Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. Gastroenterol. 2016;150(6):1262-79.e2.

Whitehead WE, Drossman DA, Chang L, Chey WD, Kellwow J, Tack J. Rome IV diagnostic questionnaires and tables for investigators and clinicians. 1st ed. Rome Foundation, Raleigh, North Carolina; 2017.

Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterol. 2016;150(6): 1393-1407.e5.

Häuser W, Layer P, Henningsen P, Kruis W. Functional bowel disorders in adults. Dtsch Ärzteblatt Int. 2012;109(5):83–94.

Thompson WG. Irritable bowel syndrome in general practice: Prevalence, characteristics and referral. Gut. 2000; 46(1):78–82.

Ibrahim NK. A systematic review of the prevalence and risk factors of irritable bowel syndrome among medical students. Turk J Gastroenterol. 2016;27(1):10–6.

Wald A, Hinds JP, Caruana BJ. Psychological and physiological characteristics of patients with severe idiopathic constipation. Gastroenterol. 1989;97(4):932-7.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130(5):1480–91.

Cann PA, Read NW, Cammack J, Childs H, Holden S, Kashman R, et al. Psychological stress and the passage of a standard meal through the stomach and small intestine in man. Gut. 1983; 24(3):236–40.

Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterol. 2006;130(5):1480–91.

Jemilohun AC, Abayomi O, Adebayo PB. Prevalence of irritable bowel syndrome, psychological ill-health and health-seeking behavior in a population of Nigerian Medical Students. J Adv Med Med Res. 2018;1–9.

Onyekwere CA, Asiyanbi A, Obi J. PWE-002 IBS in Nigeria; is there a decline in prevalence? Gut. 2012;61(Suppl 2):A297–A297.

Okeke EN, Ladep NG, Adah S, Bupwatda PW, Agaba EI, Malu AO. Prevalence of irritable bowel syndrome: A community survey in an African population. Ann Afr Med. 2009;8(3):177–80.

Okeke EN, Agaba EI, Gwamzhi L, Achinge GI, Angbazo D, Malu AO. Prevalence of irritable bowel syndrome in a Nigerian student population. Afr J Med Med Sci. 2005;34(1):33–6.

Akere A, Oyewole A. Prevalence of irritable bowel syndrome among psychiatric patients. Nigerian J Gastroenterol Hepatol. 2013;5(2):85–9.

Olubuyide IO, Olawuyi F, Fasanmade AA. A study of irritable bowel syndrome diagnosed by Manning criteria in an African population. Dig Dis Sci. 1995; 40(5):983–5.

Akere A, Akande KO. Association between irritable bowel syndrome and shift work: Prevalence and associated factors among nurses. J Gastroenterol Hepatol Res. 2014;3(11):1328–31.

Ladep N-G, Obindo T-J, Audu M-D, Okeke E-N, Malu A-O. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol. 2006;12(48):7844–7.

Nwokediuko SC, Adekanle O, Akere A, Olokoba A, Anyanechi C, Umar MS et al. Irritable bowel syndrome in Nigeria: Disparity between the North and the South. Nigerian J Gastroenterol Hepatol. 2019; 11(1):9-14

Araoye MO. Sample size determination. Research methodology with statistics for health and social sciences. 1st Ed. Ilorin: Nathadex Publishers. 2004;115-120.

Vanner SJ, Depew WT, Paterson WG, DaCosta LR, Groll AG, Simon JB, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94(10):2912– 7.

Dong Y-Y, Zuo X-L, Li C-Q, Yu Y-B, Zhao Q-J, Li Y-Q. Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria. World J Gastroenterol. 2010; 16(33):4221–6.

Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32(9):920–4.

Rao SSC, Camilleri M, Hasler WL, Maurer AH, Parkman HP, Saad R, et al. Evaluation of gastrointestinal transit in clinical practice: Position paper of the American and European Neuro gastroenterology and Motility Societies. Neurogastroenterol Motil. 2011;23(1):8– 23.

Riegler G, Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech Coloproctology. 2001;5(3):163–4.

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56(6):893–7.

Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444–58.

Osman A, Hoffman J, Barrios FX, Kopper BA, Breitenstein JL, Hahn SK. Factor structure, reliability, and validity of the Beck Anxiety Inventory in adolescent psychiatric inpatients. J Clin Psychol. 2002;58(4):443–56.

Muntingh ADT, van der Feltz-Cornelis CM, van Marwijk HWJ, Spinhoven P, Penninx BWJH, van Balkom AJLM. Is the beck anxiety inventory a good tool to assess the severity of anxiety? A primary care study in the Netherlands Study of Depression and Anxiety (NESDA). BMC Fam Pract. 2011; 12:66.

Wetherell JL, Areán PA. Psychometric evaluation of the beck anxiety inventory with older medical patients. Psychol Assess. 1997;9(2):136–44.

Quintão S, Delgado AR, Prieto G. Validity study of the beck anxiety inventory (Portuguese version) by the rasch rating scale model. Psicol Reflex E Crítica. 2013; 26(2):305–10.

Nordberg SS, Moltu C, Råbu M. Norwegian translation and validation of a routine outcomes monitoring measure: The treatment outcome package. Nord Psychol. 2016;68(2):124–43.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–71.

Bremner JD, Bolus R, Mayer EA. Psychometric properties of the Early Trauma Inventory-Self Report. J Nerv Ment Dis. 2007;195(3):211–8.

Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.

Bhandari NR, Kathe N, Hayes C, Payakachat N. Reliability and validity of SF-12v2 among adults with self-reported cancer. Res Soc Adm Pharm RSAP. 2018; 14(11):1080–4.

Hayes CJ, Bhandari NR, Kathe N, Payakachat N. Reliability and Validity of the Medical Outcomes Study Short Form-12 Version 2 (SF-12v2) in Adults with Non-Cancer Pain. Healthcare (Basel). 2017; 5(2):22.